The Sol Goldman Pancreatic Cancer Research Center

Pancreas Multidisciplinary Cancer Team

Our Team

The Multidisciplinary Pancreatic Cancer Team at Johns Hopkins is committed to providing the highest level of care to individuals suffering from pancreatic cancer and related conditions. Our team is comprised of many of the world's leading experts in pancreatic cancer.


A Message of Hope...

A Message of Hope

On Saturday March 24, 2013, members of the Baltimore and the Washington, D.C. affiliates of PanCAN visited the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins. Approximately 50 patients, family members and advocates visited.
More...


Experience is Important

Surgeons at Johns Hopkins performed more pancreatic cancer resections than any other institution in the world. More...


Pancreatic Cancer News

Patients who have an IPMN surgically resected need to be followed clinically

The team from Hopkins recently reported their experience with close to 450 patients who had an intraductal papillary mucinous neoplasm (IPMN) of the pancreas resected. In the study, reported in the Annals of Surgery (PMID 33201121), the authors clinically followed 449 consecutive patients who had a non-invasive IPMN surgically resected at Johns Hopkins between 1995 and 2018. Remarkably, 16 (3.6%) of the patients developed an invasive cancer in their remnant pancreas during the period of follow-up. The authors estimated the risk of progression was 6.4% at five years after surgery, and 12.9% at 10 years after surgery. These results add to the growing body of evidence that suggest that patients should be clinically followed after they have had surgery for an IPMN because they have a small, but real, risk of developing cancer in their remnant pancreas.


more news...


Support our Research!

Support

Donate to our Pancreatic Cancer Research, Raise Awareness, become Involved and Spread the Word. Private giving has provided us with the opportunity to make real advances in our understanding of pancreas cancer and it has provided critical support to our young investigators. Please consider supporting our research.

More...